Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Sbarrato

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cellsThomas C J Tan, John Knight, Thomas Sbarrato, et al.
RNA (New York, N.Y.)|August 27, 2017
An improved analysis methodology for translational profiling by microarrayThomas Sbarrato, Ruth V Spriggs, Lindsay Wilson, et al.
Cell Death & Disease|March 16, 2018
Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4Joy Ogbechi, Belinda S Hall, Thomas Sbarrato, et al.
Biophysical Journal|January 14, 2020
A Bistable Mechanism Mediated by Integrins Controls Mechanotaxis of LeukocytesAlexander Hornung, Thomas Sbarrato, Nicolas Garcia-Seyda, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
TAp73 contributes to the oxidative stress response by regulating protein synthesisAlberto Marini, Barak Rotblat, Thomas Sbarrato, et al.
Current Biology : CB|February 28, 2017
RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3Amandine Bastide, Diego Peretti, John R P Knight, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancerFlorence Marliot, Xiaoyi Chen, Amos Kirilovsky, et al.
Ebiomedicine|May 27, 2023
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancerFrançois Ghiringhelli, Frederic Bibeau, Laurent Greillier, et al.
The Lancet. Oncology|May 31, 2022
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trialCarlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cellsThomas C J Tan, John Knight, Thomas Sbarrato, et al.
RNA (New York, N.Y.)|August 27, 2017
An improved analysis methodology for translational profiling by microarrayThomas Sbarrato, Ruth V Spriggs, Lindsay Wilson, et al.
Cell Death & Disease|March 16, 2018
Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4Joy Ogbechi, Belinda S Hall, Thomas Sbarrato, et al.
Biophysical Journal|January 14, 2020
A Bistable Mechanism Mediated by Integrins Controls Mechanotaxis of LeukocytesAlexander Hornung, Thomas Sbarrato, Nicolas Garcia-Seyda, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
TAp73 contributes to the oxidative stress response by regulating protein synthesisAlberto Marini, Barak Rotblat, Thomas Sbarrato, et al.
Current Biology : CB|February 28, 2017
RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3Amandine Bastide, Diego Peretti, John R P Knight, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancerFlorence Marliot, Xiaoyi Chen, Amos Kirilovsky, et al.
Ebiomedicine|May 27, 2023
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancerFrançois Ghiringhelli, Frederic Bibeau, Laurent Greillier, et al.
The Lancet. Oncology|May 31, 2022
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trialCarlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Pageof 1